figshare
Browse
pone.0234539.g004.tif (897.65 kB)

Distinguishing sera from CABG patients versus control individuals using LOOCV mass peak and sample randomization analyses.

Download (897.65 kB)
figure
posted on 2020-08-05, 18:15 authored by James R. Hocker, Megan Lerner, Stan A. Lightfoot, Marvin D. Peyton, Jess L. Thompson, Subrato Deb, Mathew Reinersman, R. Jane Hanas, Russel G. Postier, Barish H. Edil, Harold M. Burkhart, Jay S. Hanas

(A) Serum discrimination of CAD patients before CABG procedure (triangles) from control individuals (circles) by % of LOOCV CABG classified mass peaks. A cut off value is present (- or + SDs [standard deviations] from the CABG or control groups respectively) to determine test metric values (e.g. true positives). Patients with an “*” represent those with T2DM; darkened symbols indicate male subjects. (B) Non-serum sample discrimination when the two different sample groups from (A) are mixed together randomly followed by the same LOOCV mass peak analysis.

History